EXOMEseq_of_HIPSCI_clones-sc-5915
EXOMEseq_of_HIPSCI_clones
After genetic modification of the KOLF2C1 human Induced Pluripotent Stem cell, we are confirming the absence of additional somatic variants by performing Exome sequencing.  KOLF3 IPSC subclones are also being run in parallel. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/
After genetic modification of the KOLF2C1 human Induced Pluripotent Stem cell, we are confirming the absence of additional somatic variants by performing Exome sequencing.  KOLF3 IPSC subclones are also being run in parallel.